Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources

Abstract

BackgroundMost estimates for End Stage Kidney Disease (ESKD) prevalence and incidence are based on renal replacement therapy (RRT) registers. However, not all people with ESKD will commence RRT and estimates based only on RRT registry data will underestimate the true burden of ESKD in the community. This study estimates the total number of Northern Territory (NT) residents with ESKD including: those receiving RRT, those diagnosed but not receiving RRT and an estimate of “undiagnosed” cases.MethodsFour data sources were used to identify NT residents with a diagnosis of ESKD: public hospital admissions, Australia and New Zealand Dialysis and Transplant Registry registrations, death registrations and, for the Aboriginal population only, electronic primary care records. Three data sources contained information recorded between 1 July 2008 and 31 December 2013, death registration data extended to 31 December 2014 to capture 2013 prevalent cases. A capture–recapture method was used to estimate both diagnosed and undiagnosed cases by making use of probability patterns of overlapping multiple data sources.ResultsIn 2013, the estimated ESKD prevalence in the NT Aboriginal population was 11.01 (95% confidence interval (CI) 10.24–11.78) per 1000, and 0.90 (95% CI 0.76–1.05) per 1000 in the NT non-Aboriginal population. The age-adjusted rates were 17.97 (95% CI 17.82–18.11) and 1.07 (95% CI 1.05–1.09) per 1000 in the NT Aboriginal and non-Aboriginal populations respectively. The proportion of individuals receiving RRT was 71.4% of Aboriginal and 75.5% of non-Aboriginal prevalent ESKD cases. The age-adjusted ESKD incidence was also greater for the Aboriginal (5.26 (95% CI 4.44–6.08) per 1000 population) than non-Aboriginal population (0.36 (95% CI 0.25–0.47) per 1000).ConclusionThis study provides comprehensive estimates of the burden of ESKD including those cases that are not identified in relevant health data sources. The results are important for informing strategies to reduce the total burden of ESKD and to manage the potential unmet demand, particularly from comparatively young Aboriginal patients who may be suitable for RRT but do not currently access the services for social, geographic or cultural reasons.Electronic supplementary materialThe online version of this article (doi: 10.1186/s12882-017-0791-3) contains supplementary material, which is available to authorized users.

Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage study

“…The HRN and other personal identifiers are routinely stored in a centralised Client Master Index, which connects to and synchronises across various NT Health information systems, including both PCIS and the Hospital Inpatient Activity data set. The Client Master Index is subject to continual audit and review and is deemed reliable for deterministic linkage in research 13 14. Implementation of PCIS commenced in 2004 and was completed by 2010.…”

The stay strong app as a self-management tool for first nations people with chronic kidney disease: a qualitative study

“…The NT also has the highest incidence and prevalence of chronic kidney disease requiring kidney replacement therapy including haemodialysis, peritoneal dialysis or kidney transplantation [ 12 ]. Furthermore, age adjusted prevalence for the NT First Nations population is up to 17 times that of the non-First Nations population [ 13 , 14 ]. The link between increasing disease burden and health expenditure highlights the need to explore new, more effective intervention strategies.…”

Risk factors for HTLV‐1, acute kidney injury, and urinary tract infection among aboriginal adults with end stage kidney disease in central Australia

“…The prevalence of CKD is twofold higher among Aboriginal Australians 3 who are also nearly four times more likely to die as a consequence of CKD than nonindigenous Australians 2 . The Northern Territory (NT) of Australia is a global CKD hotspot 4 in which the age‐adjusted end stage kidney disease (ESKD) prevalences for the Aboriginal and non‐Aboriginal populations were 18 and 1 per 1000, respectively 5 . The region also has the highest recorded prevalence of infection with the Human T‐cell Leukemia Virus Type 1 (HTLV‐1) worldwide 6 …”